Delusional Depression in Parkinson's Disease

References

• Baruch P., Jouvet R., Vindreau R. Improvement of parkinsonism in ECT-treated depressed patients: Parkinson's disease or depression-related extrapyramidal disorder. Abstracts of the World Congress of Biological Psychiatry 1985; 452: 2
   Google Scholar
• Cash R., Dennis T., L'Heureux R. Parkinson's disease and dementia: Norepinephrine and dopamine in locus coeruleus. Neurology 1987; 37: 42–46
   PubMed Web of Science ®Google Scholar
• Celesia G.G., Wanamaker W.M. Psychiatric disturbances in Parkinson's disease. Diseases of the Nervous System 1972; 33: 577–583
   PubMedGoogle Scholar
• Charney D.S., Nelson J.C. Delusional and nondelusional unipolar depression: further evidence for distinct subtypes. American Journal of Psychiatry 1981; 138: 328–333
   PubMed Web of Science ®Google Scholar
• Deleon-Jones F., Maas J.W., Dekirmenjian H. Diagnostic subgroups of affective disorders and their urinary excretion of catecholamine metabolites. American Journal of Psychiatry 1975; 132: 1141–1148
   PubMed Web of Science ®Google Scholar
• Fink M. ECT for Parkinson's disease. Convulsive Therapy 1988; 4: 189–191
   PubMedGoogle Scholar
• Frances A., Brown R.P., Kocis J.H. Psychotic depression: A separate entity. American Journal of Psychiatry 1981; 138: 831–833
   PubMed Web of Science ®Google Scholar
• Friedman J.H., Lannon M.C. Clozapine in the treatment of psychosis in Parkinson's disease. Neurology 1989; 39: 1219–1221
   PubMed Web of Science ®Google Scholar
• Glassman A.H., Kantor S.J., Shostak M. Depression, delusions, and drug response. American Journal of Psychiatry 1975; 132: 716–719
   PubMed Web of Science ®Google Scholar
• Glassman A.H., Roose S.P. Delusional depression. A distinct clinical entity. Archives of General Psychiatry 1981; 38: 424–427
   PubMed Web of Science ®Google Scholar
• Goetz C.G. Drug-induced parkinsonism and idiopathic Parkinson's disease. Archives of Neurology 1983; 40: 325–326
   PubMedGoogle Scholar
• Gotham A.M., Brown R.G., Marsden C.D. Depression in Parkinson's disease: a qualitative analysis. Journal of Neurology Neurosurgery and Psychiatry 1986; 49: 381–389
   PubMed Web of Science ®Google Scholar
• Greenfield J.G., Bosanquet F.D. Brain-stem lesions in parkinsonism. Journal of Neurology, Neurosurgery and Psychiatry 1953; 16: 213–226
   PubMed Web of Science ®Google Scholar
• Hoehn M.M., Crowley T.J., Rutledge C.O. Dopamine correlates of neurological and psychological status in untreated parkinsonism. Journal of Neurology, Neurosurgery and Psychiatry 1976; 39: 941–951
   PubMed Web of Science ®Google Scholar
• Huber S.J., Paulson G.W., Shuttleworth E.C. Depression in Parkinson's disease. Neuropsychiatry, Neuropsychology and Behavioral Neurology 1988; 1: 47–51
   Google Scholar
• Hurst J.H., LeWitt P.A., Bums R.S. CSF dopamine beta-hydroxylase activity in Parkinson's disease. Neurology 1985; 35: 565–568
   PubMed Web of Science ®Google Scholar
• Kawamura T., Kinoshita M., Iwasaki Y. Low-dose dexamethasone suppression test in Japanese patients with Parkinson's disease. Journal of Neurology 1987; 234: 264–265
   PubMed Web of Science ®Google Scholar
• Kettering R.L., Harrow M., Grossman L. The prognostic relevance of delusions in depression: A follow-up study. American Journal of Psychiatry 1987; 144: 1154–1160
   PubMed Web of Science ®Google Scholar
• Kostic V.S., Djuricic B.M., Covicovic-Stemic N. Depression and Parkinson's disease: Possible role of serotonergic mechanisms. Journal of Neurology 1987; 234: 94–96
   PubMed Web of Science ®Google Scholar
• Kuhn W., Fuchs G., Laux G. Clinical and biochemical characteristics of early depression in Parkinson's disease. Early diagnosis and preventive therapy in parkinson's disease, H. Pruzentek, P. Riederer. Springer Verlag., Wien 1989; 49–54
   Google Scholar
• Lieberman A.N., Freedman L.S., Goldstein M. Parkinson's disease. Lancet 1972; 1: 153–154
   PubMedGoogle Scholar
• Lieberman J.A., Saltz B.L., Johns C.A. Clozapine effects on tardive dyskinesia. Psychopharmacology Bulletin 1989; 25: 57–62
   PubMedGoogle Scholar
• Lindstrom L.H. The effect of long-term treatment with clozapine in schizophrenia: A retrospective study of 96 patients treated with clozapine for up to 13 years. Acta Psychiatrica Scandinavica 1988; 77: 524–529
   PubMed Web of Science ®Google Scholar
• Mayeux R., Stem Y., Rosen J. Depression, intellectual impairment, and Parkinson's disease. Neurology 1981; 31: 645–650
   PubMed Web of Science ®Google Scholar
• Mayeux R. Mental State. Handbook of parkinson's disease, W.C. Koller. Marcel Dekker., New York 1987; 127–144
   Google Scholar
• Mayeux R., Stern Y., Williams J. B. W. Clinical and biochemical features of depression in Parkinson's disease. American Journal of Psychiatry 1986; 143: 756–759
   PubMed Web of Science ®Google Scholar
• Mayeux R., Stem Y., Sano M. The relationship of serotonin to depression in Parkinson's disease. Movement Disorders 1988; 3: 237–244
   PubMed Web of Science ®Google Scholar
• Meltzer H.Y., Cho H.W., Carroll B. Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients. Archives of General Psychiatry 1976; 33: 585–591
   PubMed Web of Science ®Google Scholar
• Mindham R. H. S. Psychiatric symptoms in parkinsonism. Journal of Neurology, Neurosurgery and Psychiatry 1970; 33: 188–191
   PubMed Web of Science ®Google Scholar
• Mindham R. H. S., Marsden C.D., Parkes J.D. Psychiatric symptoms during L-dopa therapy for Parkinson's disease and their relationship to physical disability. Psychological Medicine 1976; 6: 23–33
   PubMed Web of Science ®Google Scholar
• Minter R.E., Mandel M.R. The treatment of psychotic major depressive disorder with drugs and electroconvulsive therapy. Journal of Nervous and Mental Disease 1979; 167: 726–133
   PubMed Web of Science ®Google Scholar
• Nelson J.C., Bowers M.B. Delusional unipolar depression: description and drug response. Archives of General Psychiatry 1978; 35: 1321–1328
   PubMed Web of Science ®Google Scholar
• Rajput A.H., Rozdilsky B., Hornykiewicz O., Shannak K., Lee T., Seeman P. Reversible drug-induced parkinsonism: clinico-pathologic study of two cases. Archives of Neurology 1982; 39: 644–646
   PubMedGoogle Scholar
• Routh L.C., Black J.L., Ahlskog J.E. Parkinson's disease complicated by anxiety. Mayo Clinic Proceedings 1987; 62: 733–735
   PubMed Web of Science ®Google Scholar
• Sano M., Stern Y., Williams J., Cote L., Rosenstein R., Mayeux R. Coexisting dementia and depression in Parkinson's disease. Archives of Neurology 1989; 46: 1284–1286
   PubMedGoogle Scholar
• Santamaria J., Tolosa E., Valles A. Parkinson's disease with depression: A possible subgroup of idiopathic parkinsonism. Neurology 1986; 36: 1130–1133
   PubMed Web of Science ®Google Scholar
• Schiffer R.B., Kurlan R., Rubin A. Evidence for atypical depression in Parkinson's disease. American Journal of Psychiatry 1988; 145: 1020–1022
   PubMed Web of Science ®Google Scholar
• Stein M.B., Heuser I.J., Juncos J.L. Anxiety disorders in patients with Parkinson's disease. American Journal of Psychiatry 1990; 147: 217–220
   PubMed Web of Science ®Google Scholar
• Stern S.L., Hurtig H.I., Mendels J. Psychiatric illness in relatives of patients with Parkinson's disease: A preliminary report. American Journal of Psychiatry 1977; 134: 443–444
   PubMed Web of Science ®Google Scholar
• Stern Y., Mayeux R., Lucien C. Reaction time and vigilance in Parkinson's disease. Possible role of altered norepinephrine metabolism. Archives of Neurology 1984; 41: 1086–1089
   PubMedGoogle Scholar
• Sternberg D.E., Van Kammen D.P., Lerner P. CSF dopamine-beta hydroxylase in schizophrenia. Archives of General Psychiatry 1983; 40: 743–747
   PubMed Web of Science ®Google Scholar
• Sweeney D., Nelson C., Bowers M. Delusional versus nondelusional depression: neurochemical differences. Lancet 1978; 2: 100–101
   PubMed Web of Science ®Google Scholar
• Taylor A.E., Saint-Cyr J.A., Lang A.E. Parkinson's disease and depression: a critical re-evaluation. Brain 1986; 109: 279–292
   PubMed Web of Science ®Google Scholar
• Tune L.E., Folstein M., Rabins P. Familial manic-depressive illness and familial Parkinson's disease: A case report. The Johns Hopkins Medical Journal 1982; 151: 65–70
   PubMedGoogle Scholar
• Van Praag H.M., Korf J., Lakke J.D. W. F., Schut T. Dopamine metabolism in depression, psychosis, and Parkinson's disease. Psychological Medicine 1975; 5: 138–146
   PubMedGoogle Scholar
• Weissman M.M., Prusoff B.A., Merikangas K.R. Is delusional depression related to bipolar disorder. American Journal of Psychiatry 1984; 141: 892–893
   PubMed Web of Science ®Google Scholar
• Whitlock F.A. The psychiatric complications of Parkinson's disease. Australian and New Zealand Journal of Psychiatry 1986; 20: 114–121
   PubMed Web of Science ®Google Scholar
• Wolters E. C. H., Hurwitz T.A., Peppard R.F., Calne D.B. Clozapine: An antipsychotic agent in Parkinson's disease. Clinical Neuropharmacology 1989; 12: 83–90
   PubMed Web of Science ®Google Scholar